Income Statement
CONTEXT THERAPEUTICS INC.
CNTX
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - |
|
Operating Expenses
|
7.85 | 7.22 | 7.29 | 7.79 | 3.63 |
|
Research & Development
|
31.86 | 22.70 | 17.78 | 7.09 | 3.81 |
|
Selling, General & Administrative
|
7.85 | 7.22 | 7.29 | 7.79 | 3.63 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-7.85 | -7.22 | -7.29 | -7.79 | -3.63 |
|
Non-Operating Income
|
- | - | -0.06 | 0.00 | 0.12 |
|
Interest Income
|
3.38 | 3.20 | - | - | - |
|
Interest Expense
|
- | - | - | - | 0.06 |
|
Other Non-Op Income / Expense
|
0.20 | 0.00 | - | - | - |
|
Income Before Tax
|
- | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-36.12 | -26.73 | -23.96 | -14.84 | -10.46 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-7.83 | -7.21 | -7.28 | -7.78 | -3.63 |
|
Earnings Per Share (Basic)
|
-0.38 | -0.46 | -1.50 | -0.93 | -3.69 |
|
Diluted EPS
|
-0.38 | -0.46 | -1.50 | -0.93 | -3.69 |
|
Weighted Average Shares
|
95.19 | 58.42 | 15.97 | 15.97 | 2.83 |
|
Diluted Weighted Avg Shares
|
95.19 | 58.42 | 15.97 | 15.97 | 2.83 |
|
Comprehensive Income
|
- | - | - | - | - |